A Multicentric, Retrospective Efficacy and Safety Study of Nanosomal Docetaxel Lipid Suspension in Metastatic Castration-Resistant Prostate Cancer.

Aseem SamarSrikant TiwariSundaram SubramanianNisarg JoshiJaykumar SejpalMujtaba A KhanImran Ahmad

Published in: Prostate cancer (2020)

Nanosomal docetaxel lipid suspension (2-weekly or 3-weekly) was effective and well tolerated in patients with metastatic castration-resistant prostate cancer.

Keyphrases

squamous cell carcinoma
small cell lung cancer
locally advanced
fatty acid
cross sectional
radiation therapy